GFV One, Inc. – Trademark Portfolio

Entity Type: 03

GFV One, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 28 (Toys & Sporting Goods) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include GM2 GRIP and CRAMPCAREH. The owner is based in Sunnyvale, CA.

1095 W El Camino Real, Unit 141

Sunnyvale, CA 94087

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

GM2 GRIP
GM2 GRIP
Registered 2024
GM2
GM2
Abandoned 2021

Trademark Classifications

GFV One, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

28
Toys & Sporting Goods (2 filings)

Games and playthings; gymnastic and sporting articles; decorations for Christmas trees

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does GFV One, Inc. have?

GFV One, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does GFV One, Inc. file in?

GFV One, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 28 (Toys & Sporting Goods), Class 10 (Medical Apparatus). Class 28 covers games and playthings; gymnastic and sporting articles; decorations for christmas trees.

What are GFV One, Inc.'s most well-known trademarks?

GFV One, Inc.'s registered trademark portfolio includes well-known marks such as GM2 GRIP and CRAMPCAREH. These are among 2 currently registered trademarks in the portfolio.

What is GFV One, Inc.'s trademark registration success rate?

GFV One, Inc. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.